Trials / Completed
CompletedNCT01324271
inVENT-In-Office Study
A Clinical Study Of The Acclarent Tympanostomy Tube (Tula™) Delivery System In-Office
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TTDS) for the placement of tympanostomy tubes (TT) under local anesthesia in an office/clinic setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acclarent Tympanostomy Tube Delivery system (TTDS) | placement of tympanostomy tube under local anesthesia |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2011-03-29
- Last updated
- 2024-08-06
- Results posted
- 2014-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01324271. Inclusion in this directory is not an endorsement.